Advance Search
ZHANG Jianhui, WANG Lin, CAO Saisai. Effect of atorvastatin calcium in the treatment of unstable angina pectoris and its impact on inflammatory response[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 73-75, 79. DOI: 10.7619/jcmp.201923022
Citation: ZHANG Jianhui, WANG Lin, CAO Saisai. Effect of atorvastatin calcium in the treatment of unstable angina pectoris and its impact on inflammatory response[J]. Journal of Clinical Medicine in Practice, 2019, 23(23): 73-75, 79. DOI: 10.7619/jcmp.201923022
shu

Effect of atorvastatin calcium in the treatment of unstable angina pectoris and its impact on inflammatory response

  • 1.

    Outpatient Department, Garrison Command First Retired Cadre Rest Centerin Dongcheng District, Beijing, 100000

  • 2.

    Department of Cardiovascular Medicine, General Hospital of People′s Liberation Army, Beijing, 100120

More Information
  • Received Date: September 10, 2019
  • Accepted Date: November 03, 2019
  • Available Online: February 28, 2021
  • Published Date: December 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effect of atorvastatin calcium in the treatment of unstable angina pectoris and its effect on inflammation reaction.
      Methods  A total of 70 patients with unstable angina pectoris admitted to our hospital were selected and divided into two groups according to the treatment plan. Patients in the control group (n=30)were treated with routine treatment, while those in the observation group (n=40) were treated with atorvastatin calcium on the basis of routine treatment. The clinical efficacy, angina pectoris attack, blood lipid level, hemorheological index, inflammatory factor level and incidence of adverse reactions were compared between the two groups.
      Results  The total clinical effective rate was 95.00% in the observation group and 76.67% in the control group, there was a statistical significant difference (P < 0.05). The number of angina attacks in the observation group was less, and its duration in the observation group was shorter than that in the control group(P < 0.05). After treatment, the levels of total cholesterol, triglyceride, hematocrit (HCT), hematocyte sedimentation rate (ESR), plasma viscosity (PV), C reactive protein (CRP) and interleukin-6 (IL-6) levels in the observation group were lower than those in the control group (P < 0.05). The incidence of adverse reactions showed no significant difference in two groups (P>0.05).
      Conclusion  Atorvastatin calcium with higher safety for patients with unstable angina pectoris can effectively control the onset of angina pectoris, reduce blood lipid levels, improve hemorheological indicators, reduce inflammation reactions, and do not increase adverse reactions.
    • FullText(HTML)
    • References (15)
  • [1]
    陈涵, 王江友, 尚小珂, 等. 阿托伐他汀联合曲美他嗪对不稳定型心绞痛患者经皮冠状动脉介入治疗围术期心肌损伤及炎性因子的影响[J]. 中国介入心脏病学杂志, 2014, 22(11): 689-692. doi: 10.3969/j.issn.1004-8812.2014.11.003
    [2]
    许先继, 林艳足. 阿托伐他汀联合氯吡格雷对不稳定型心绞痛患者血清高敏C反应蛋白及预后的影响[J]. 广东医学, 2014, 35(11): 1766-1768. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201411054.htm
    [3]
    吕静, 徐戈, 黄琛, 等. 强化剂量阿托伐他汀对不稳定型心绞痛患者经皮冠脉介入术围手术期B7-H4的影响[J]. 实用医学杂志, 2017, 33(6): 975-978. doi: 10.3969/j.issn.1006-5725.2017.06.034
    [4]
    郭筱燕, 黄学成, 王琦武, 等. 不同负荷剂量阿托伐他汀钙对不稳定型心绞痛患者冠状动脉介入治疗术后的影响[J]. 中国动脉硬化杂志, 2014, 22(10): 1039-1043. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201410014.htm
    [5]
    章晨, 郑永. 阿托伐他汀对不稳定型心绞痛患者的疗效及心血管事件的影响[J]. 中国生化药物杂志, 2017, 37(5): 318-320. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYB201503020.htm
    [6]
    康玲玲. 阿托伐他汀联合氯吡格雷对不稳定型心绞痛患者超敏C-反应蛋白及预后的影响[J]. 中国中西医结合急救杂志, 2019, 26(2): 181-183. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201411054.htm
    [7]
    吕丽丽, 王光彦, 崔红花, 等. 阿托伐他汀联合法舒地尔对不稳定型心绞痛患者血清IL-23水平的影响[J]. 中国老年学杂志, 2015, 35(4): 893-895. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201504013.htm
    [8]
    Gul M, Uyarel H, Ergelen M, et al. Predictive value of neutrophil to lymphocyte ratio in clinical outcomes of non-ST elevation myocardial infarction and unstable angina pectoris: A 3-year follow-up[J]. Clinical and applied thrombosis/hemostasis, 2014, 20(4): 378-384. doi: 10.1177/1076029612465669
    [9]
    刘云, 梁生. 阿托伐他汀对不稳定型心绞痛患者hs-CRP、Hcy及cTnⅠ水平的影响研究[J]. 现代中西医结合杂志, 2018, 27(4): 400-402. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH201804019.htm
    [10]
    邵玲. 阿托伐他汀对不稳定型心绞痛老年患者疗效及内皮功能的影响[J]. 中国动脉硬化杂志, 2015, 23(3): 304-306. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201503019.htm
    [11]
    朱创键, 吴攀峰, 张金飞, 等. 阿托伐他汀强化降脂治疗对不稳定型心绞痛患者血脂、血清血管性假血友病因子与血栓调节蛋白水平的影响[J]. 中国药师, 2015, 18(1): 94-96. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYSG201501032.htm
    [12]
    付熠, 王蔚浩, 邵超华, 等. 阿托伐他汀对不稳定型心绞痛患者IL-6、MMP-9及心血管事件的影响[J]. 南昌大学学报: 医学版, 2015, 55(3): 69-71. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYB201503020.htm
    [13]
    李淑琴, 张宝琛, 王聚付, 等. 大剂量阿托伐他汀钙治疗不稳定型心绞痛50例近期疗效观察[J]. 中国药业, 2014, 23(13): 109-110. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGZ201413063.htm
    [14]
    黄琛, 徐戈, 吕静, 等. 阿托伐他汀强化治疗对不稳定型心绞痛患者PCI围术期心肌梗死及白介素水平的影响[J]. 广西医科大学学报, 2017, 34(2): 202-205. https://www.cnki.com.cn/Article/CJFDTOTAL-GXYD201702009.htm
    [15]
    何苏利. 阿托伐他汀联合曲美他嗪治疗不稳定型心绞痛疗效分析[J]. 中国基层医药, 2014, 21(1): 127-129. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYX201406008.htm
    • Related Articles

  • Related Articles

    [1]GAO Xianru, ZENG Qingping, LI Mengyao, LI Yuping, TAN Yuerong, WANG Jia, SHI Tian. Bibliometric analysis of domestic and foreign studies on dysphagia after stroke in the past decade[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 127-133. DOI: 10.7619/jcmp.20223226
    [2]YANG Ling, LEI Ming, CHEN Qun, ZHAO Xiao, YU Xiaoxia. Clinical study on Weijin Xiangjiao acupuncture in the treatment of dysphagia after ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(20): 30-34. DOI: 10.7619/jcmp.20221050
    [3]BAI Xue, LI Bing, LI Hua, GONG Qiwei, FENG Ling. Effect of early swallowing and feeding intervention on dysphagia and quality of life in postoperative patients with tongue cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 46-50. DOI: 10.7619/jcmp.20220199
    [4]DAI Suyun, XIANG Wenhai, CUI Lisheng, OUYANG Yuchen, DING Jie, FENG Huiping, DONG Jiahao. Oral sensation training in patients with dysphagia and salivation after stroke[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 6-10. DOI: 10.7619/jcmp.20213872
    [5]XU Jiehui, HAO Zhina, PIAO Jingjing, GU Yanmei. Effect of timing acupoint stimulation for dysphagia patients after stroke[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 70-75. DOI: 10.7619/jcmp.20211546
    [6]HU Yue. Rehabilitation nursing of traditional Chinese medicine in patients with dysphagia after stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 78-81. DOI: 10.7619/jcmp.202011022
    [7]CHEN Xinxing, TIAN Ling. Timing selection of acupuncture and rehabilitation training for patients with dysphagia after stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 123-125. DOI: 10.7619/jcmp.202006034
    [8]LIU Guoju, DING Yun, CHENG Yuefeng, LIANG Caihong. Effect of drinking water test combined with swallowing training for the treatment of cerebral infarction patients with dysphagia[J]. Journal of Clinical Medicine in Practice, 2018, (2): 5-8. DOI: 10.7619/jcmp.201802002
    [9]ZHAO Feili, ZHANG Chunni. Effect of time rehabilitation nursing on functional rehabilitation of cerebral infarction patients with dysphagia[J]. Journal of Clinical Medicine in Practice, 2016, (6): 10-12. DOI: 10.7619/jcmp.201606004
    [10]Ayshemgul·Shadr, ZHAO Jie, YANG Yunxin. Effect observation of different approaches in the treatment of dysphagia in patients with cerebral stroke[J]. Journal of Clinical Medicine in Practice, 2014, (18): 72-74. DOI: 10.7619/jcmp.201418023

  • Cited by

    Periodical cited type(1)

    1. 万姜维，成东茹，王涛，高萍. 血清乳酸脱氢酶、β_2微球蛋白、铁蛋白联合改良WHO预后积分系统预测骨髓增生异常综合征预后不良的价值. 实用临床医药杂志. 2024(05): 79-84 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (253) PDF downloads (6) Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return